1. 黄荷凤 中国 复旦大学 中国科学院院士 Recurrent human 16p11.2 microdeletions in type I Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome pati..
2. Gibbs, Richard A. 美国 Baylor College of Medicine 2011美国医学院院士 Rare variant enrichment analysis supports GREB1L as a contributory driver gene in the etiology of Ma..
3. Lupski, James R. 美国 Baylor College of Medicine 2002美国医学院院士 Rare variant enrichment analysis supports GREB1L as a contributory driver gene in the etiology of Ma..
4. 邱贵兴 中国 中国医学科学院 中国工程院院士 Functional characteristics of a broad spectrum of TBX6 variants in Mayer-Rokitansky-Ku spacin..
5. Gibbs, Richard A. 美国 Baylor College of Medicine 2011美国医学院院士 Functional characteristics of a broad spectrum of TBX6 variants in Mayer-Rokitansky-Ku spacin..
6. Lupski, James R. 美国 Baylor College of Medicine 2002美国医学院院士 Functional characteristics of a broad spectrum of TBX6 variants in Mayer-Rokitansky-Ku spacin..
7. Moshe,Oren 以色列 WEIZMANN INSTITUTE OF SCIENCE 2013美国医学院院士;2019美国科学院院士 LATS1 and LATS2 suppress breast cancer progression by maintaining cell identity and metabolic state
8. 马丁 中国 华中科技大学 中国工程院院士 The nuclear protein expression levels of SNAI1 and ZEB1 are involved in the progression and lymph no..
9. Ignatia B,Van Den Veyver 美国 Baylor College of Medicine Rare variant enrichment analysis supports GREB1L as a contributory driver gene in the etiology of Ma..
10. Stylianos E,Antonarakis 瑞士 University of Geneva Rare variant enrichment analysis supports GREB1L as a contributory driver gene in the etiology of Ma..
11. Donna M,Muzny 美国 Baylor College of Medicine Rare variant enrichment analysis supports GREB1L as a contributory driver gene in the etiology of Ma..
12. Tudor I,Oprea 美国 University of New Mexico Illuminating the druggable genome through patent bioactivity data
13. Andrew R,Leach 英国 GlaxoSmithKline Illuminating the druggable genome through patent bioactivity data
14. Stylianos E,Antonarakis 瑞士 University of Geneva Functional characteristics of a broad spectrum of TBX6 variants in Mayer-Rokitansky-Ku spacin..
15. Marth, Christian 奥地利 Medicine University Innsbruck Maintenance Therapy with Aromatase Inhibitor in epithelial Ovarian Cancer (MATAO): study protocol of..
16. Andreas,Du Bois 德国 University of Duisburg-Essen Maintenance Therapy with Aromatase Inhibitor in epithelial Ovarian Cancer (MATAO): study protocol of..
17. Seyed Mohammad,Nabavi 伊朗 Baqiyatallah University Medicine Science Targeting Hippo signaling pathway by phytochemicals in cancer therapy
18. Bishayee, Anupam 美国 LAKE ERIE College OSTEOPATH Medicine Targeting Hippo signaling pathway by phytochemicals in cancer therapy
19. Ioana,Berindan-Neagoe 罗马尼亚 IULIU HATIEGANU University Medicine & Pharmacy Targeting Hippo signaling pathway by phytochemicals in cancer therapy
20. Giovanni,Scambia 意大利 University of Cattolica Sacro Cuore Towards Personalized Medicine: Non-Coding RNAs and Endometrial Cancer